Identity
- Security key
- 14873
- Ticker
- EQ
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2018-10-12
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- EQ
Detail
Enriched 2026-08-14 20:47
- Market cap
- $137,833,892.08
- Shares outstanding (class)
- 63,226,556
- Shares outstanding (weighted)
- 63,226,556
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 14
- Location
- LA JOLLA, CA
- Homepage
- https://www.equilliumbio.com
- Description
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Market cap and share counts drift.